Unum Therapeutics (UMRX, $3.32) was one of top quarterly gainers, jumping +850.2% to $3.32 per share. Tickeron A.I.dvisor analyzed 382 stocks in the Biotechnology Industry over the last three months, and discovered that 327 of them (85.6%) charted an Uptrend while 55 of them (14.4%) trended down.Tickeron A.I.dvisor found 51 similar cases when UMRX's price went up 15% within three months. In 51 out of those 51 cases, UMRX's price went down during the following month. Based on these historical data, Tickeron A.I. thinks the odds of an Uptrend reversal for UMRX are 90%.